Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171068 | SCV000050713 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000171068 | SCV000223632 | likely benign | not provided | 2021-03-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27435932, 28747690, 27711072, 23257389, 30662450, 30821013, 30847666) |
Laboratory for Molecular Medicine, |
RCV000185522 | SCV000540270 | uncertain significance | not specified | 2016-08-12 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency high for disorder; Reported in 3 probands with no seg data; ClinVar: 2 VUS |
Invitae | RCV001087315 | SCV000562320 | likely benign | Brugada syndrome 7 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000185522 | SCV000605062 | uncertain significance | not specified | 2017-03-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621217 | SCV000736435 | likely benign | Cardiovascular phenotype | 2019-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000852659 | SCV000995365 | likely benign | Cardiomyopathy | 2018-02-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000185522 | SCV003844805 | likely benign | not specified | 2023-02-15 | criteria provided, single submitter | clinical testing | Variant summary: SCN3B c.328G>A (p.Val110Ile) results in a conservative amino acid change located in the Immunoglobulin-like domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00031 in 251476 control chromosomes. The observed variant frequency is approximately 49 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN3B causing Arrhythmia phenotype (6.3e-06), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (likely benign n=4, VUS n=2, pathogenic n=1). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV003937532 | SCV004758110 | likely benign | SCN3B-related disorder | 2022-04-26 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Forensic Genetics Laboratory, |
RCV000234992 | SCV000263111 | pathogenic | Death in infancy | 2015-03-27 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000171068 | SCV001917171 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171068 | SCV001956975 | uncertain significance | not provided | no assertion criteria provided | clinical testing |